Predicta Biosciences at AMP 2026

Nov 10–14, 2026 Seattle, WA ~2k attendees Website

Predicta Biosciences brings 1 presentation to AMP 2026 in Seattle. Its session covers next-generation sequencing on Roche's AXELIOS 1 platform. The company's genome sequencing test on blood or bone marrow diagnoses and guides treatment of multiple myeloma.

OrganizationAMP 2026 Attendance
predictabiosciences.com
Diagnostics
Blood-cancer diagnostics company whose genome sequencing test on blood or bone marrow diagnoses and guides treatment of multiple myeloma.
Workshop
Wed, Nov 11
12:00pm–12:50pm
Next-Generation Sequencing with Roche’s AXELIOS 1 Platform
Roche's AXELIOS 1 sequencer and its expansion-based chemistry, covering accuracy, read length and run flexibility.
Workshop hosted by Roche Diagnostics
Yakima 1, Level 1, Arch at 800 Pike

Explore the full AMP 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Seattle. Leave your work email and we’ll be in touch.

Privacy

Download the full AMP 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Predicta Biosciences

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction